Natrx
Raleigh, US · Founded 2018 · Delaware corporation · 4 known investors
Founders & leadership
ES
Evi SteyerNamed on SEC filing
MC
Matthew CampbellNamed on SEC filing
LN
Leonard NelsonNamed on SEC filing
Investors · 4
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 3 rounds · 2021–2023
▶$709KraisedMay 2023 · 10 investors · Other TechnologyRule 506(b)
▶$709KraisedMay 2023 · 10 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew CampbellExecutive Officer, Director
- Leonard NelsonExecutive Officer, Director
- Evi SteyerDirector
- Offering amount
- $709K
- Amount sold
- $709K
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$948KraisedMay 2023 · 26 investors · Other TechnologyRule 506(b)
▶$948KraisedMay 2023 · 26 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Evi SteyerDirector
- Leonard NelsonExecutive Officer, Director
- Matthew CampbellExecutive Officer, Director
- Offering amount
- $948K
- Amount sold
- $948K
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.5MraisedMay 2023 · 2 investors · Other TechnologyRule 506(b)
▶$1.5MraisedMay 2023 · 2 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Evi SteyerDirector
- Matthew CampbellExecutive Officer, Director
- Leonard NelsonExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $1.5M
- First sale
- Apr 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Natrx for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase II | 2023 | $995.3K |
| National Science Foundation | Phase I | 2021 | $256K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- Who are Natrx's investors?
- Natrx's investors include IDEA NC, Oval Park Capital, Silverstrand Capital, Wolfpack Investor Network.
- How much funding has Natrx raised?
- Natrx has disclosed $3.2M raised across 3 rounds.
- Where is Natrx headquartered?
- Natrx is headquartered in Raleigh, US.
